Life sciences

Private Equity

Trinity Hunt Partners Invests in Supreme Optimization

Supreme Optimization is a digital marketing agency focused on life sciences.

March 14, 2023

Private Equity

WestView-Backed Frameworks Purchases Onix

Onix Life Sciences is a consultancy focused on regulatory operations services to support life sciences clients.

March 3, 2023

Healthcare

Knox Lane Invests in Spectrum Science

Spectrum Science is an independent marketing, communications and media firm focused on the pharmaceutical, biotech and life sciences industries.

February 8, 2023

Technology

Orchestra BioMed Merges with RTW’s HSAC2

Orchestra BioMed's business model focuses on forging collaborations with medical device companies to drive global commercialization of the products it develops.

January 27, 2023

Healthcare

Healthcare Experts Share M&A Concerns in New Year

Dealmakers expect a slow start to 2023 and advise against a speedy rebound in healthcare M&A.

January 9, 2023

Private Equity

Catalio Looks for New Outcomes with Public Equity Launch

The strategy is targeting global healthcare and life science equity securities that have shown growth trajectory while being mispriced.

January 5, 2023

Private Equity

Catalio Capital Launches Public Equities Strategy

The investment team from HealthCor Management, along with members of its operations, financial, administrative and marketing divisions, have agreed to join Catilio to help build out the strategy.

January 4, 2023

Technology

Advent Buys Majority Stake in Suven Pharma for $762M

Advent’s key investment areas will continue to be healthcare, consumer, financial services and information technology in India.

December 27, 2022

Sectors

This is premium content

Life sciences

Trinity Hunt Partners Invests in Supreme Optimization

WestView-Backed Frameworks Purchases Onix

Knox Lane Invests in Spectrum Science

Orchestra BioMed Merges with RTW’s HSAC2

Healthcare Experts Share M&A Concerns in New Year

Catalio Looks for New Outcomes with Public Equity Launch

Catalio Capital Launches Public Equities Strategy

Advent Buys Majority Stake in Suven Pharma for $762M

Login to your account

Life sciences

Join our Membership